Eric J Ende, Director at Matinas BioPharma, holds 167.90K shares in Avadel Pharmaceuticals (Ticker: AVDL), holds 144.09K shares in Matinas BioPharma (Ticker: MTNB), holds ― shares in Progenics (Ticker: PGNX). Most recently, Eric J Ende Bought ― shares of Avadel Pharmaceuticals on May 19, 2023 for an estimated value of 181.09K.